Picture [MSC] – The Mass Spectrometry Web Portal 600x80px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2400 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Oxford BioMedica plc. (8/7/17). "Press Release: Oxford BioMedica Announces MHRA Licence For Commercial Supply". London. 2017-08-07
Merck & Co., Inc.. (8/7/17). "Press Release: MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria. European Facility Will Boost Global Vaccine Production Capacity". Madison, NJ. 2017-08-07
Celyad S.A.. (8/4/17). "Press Release: Celyad Announces New Agreements with Celdara Medical and Dartmouth College". Mont-Saint-Guibert. 2017-08-04
Bristol-Myers Squibb Company. (8/3/17). "Press Relase: Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen Oncology Pipeline Focus on Innate Immunity". New York, NY & Boston, MA. 2017-08-03
Merck KGaA. (8/3/17). "Press Relase: European Patent Office to Grant Merck’s Patent Application for CRISPR Technology". Darmstadt. 2017-08-03
Genkyotex S.A.. (8/3/17). "Press Release: Genkyotex’s GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated Fibroblasts". Archamps & Geneva. 2017-08-03
Sygnis AG. (8/3/17). "Press Release: Sygnis AG Reports Financial Results for the Second Quarter and First Six Months of 2017". Madrid & Heidelberg. 2017-08-03
AstraZeneca plc. (8/2/17). "Press Release: US FDA Accepts Regulatory Submission for Acalabrutinib and Grants Priority Review". 2017-08-02
TC BioPharm Ltd.. (8/2/17). "Press Release: TCB Selected for EU Horizon 2020 Funding to Progress Novel, Mass-market Cell Therapies to Clinical Trial". Scotland. 2017-08-02
Zyme Communications Ltd.. (8/1/17). "Press Relase: Zyme Communications Strengthens Team and Relocates Cambridge Office". Cambridge. 2017-08-01
AstraZeneca plc. (8/1/17). "Press Release: Acalabrutinib Granted Breakthrough Therapy Designation by US FDA for the Treatment of Patients with Mantle Cell Lymphoma". 2017-08-01
Horizon Discovery Group plc. (8/1/17). "Press Release: Horizon Discovery Announces Release of High Quality, Well Annotated CHO Genome Sequence to Drive Innovation in Bioproduction". Cambridge. 2017-08-01
Bicycle Therapeutics Ltd.. (8/1/17). "Press Release: Bicycle Therapeutics Expands Leadership Team with Appointment of Lee Kalowski as Chief Financial Officer". Cambridge & Cambridge, MA. 2017-08-01
Redx Pharma plc (in administration). (7/31/17). "Press Relase: Disposal of BTK Inhibitor Drug Development Program". 2017-07-31
Laboratory Corporation of America Holdings (LabCorp). (7/31/17). "Press Relase: LabCorp to Acquire Chiltern for approximately $1.2 Billion in Cash, Advancing Its Leadership in Drug Development". Burlington, NC, London & Wilmington, NC. 2017-07-31
AstraZeneca plc. (7/31/17). "Press Release: Imfinzi Granted Breakthrough Therapy Designation by US FDA for Patients with Locally-advanced Unresectable Non-small Cell Lung Cancer". 2017-07-31
Eurofins Scientific. (7/31/17). "Press Release: Eurofins Expands Its Offering and Footprint in Drug Discovery Services with the Acquisition of DiscoverX". 2017-07-31
Thermo Fisher Scientific Inc.. (7/31/17). "Press Release: Thermo Fisher Scientific Announces Preview of the World's First Fully Integrated LC-MS/MS Clinical Analyzer at AACC 2017". San Diego, CA. 2017-07-31
Evotec AG. (7/30/17). "Press Release: Evotec to Acquire Aptuit, Expanding Leadership in External Innovation". Hamburg. 2017-07-30
Evotec AG. (7/27/17). "Press Release: Evotec Expands Collaboration with Storm Therapeutics on Its RNA Epigenetics Platform". Hamburg. 2017-07-27
AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. 2017-07-27
AstraZeneca plc. (7/27/17). "Press Release: H1 2017 Results". 2017-07-27
AstraZeneca plc. (7/27/17). "Press Release: AstraZeneca and Merck Establish Strategic Oncology Collaboration". 2017-07-27
GlaxoSmithKline plc. (7/26/17). "Press Release: GSK Delivers Further Progress in Q2 and Sets Out New Priorities for the Group". London. 2017-07-26
XL-protein GmbH. (7/26/17). "Press Release: Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation Technology to Develop Long-Acting Asparaginase Product Candidates". Freising. 2017-07-26
GlaxoSmithKline plc. (7/25/17). "Press Release: Switching to a Dolutegravir Regimen from a Boosted Protease Inhibitor Regimen Maintained Viral Suppression and Improved Lipid Fractions in Patients with HIV and High Cardiovascular Risk". London. 2017-07-25
GlaxoSmithKline plc. (7/25/17). "Press Release: ViiV Healthcare Announces Superior Efficacy of Dolutegravir versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings". London. 2017-07-25
GlaxoSmithKline plc. (7/25/17). "Press Release: Karenann Terrell Appointed Chief Digital & Technology Officer, GSK". London. 2017-07-25
One Nucleus. (7/25/17). "Press Release: Instinctif Partners Becomes Latest Partner of One Nucleus". Cambridge. 2017-07-25
Protembis GmbH. (7/25/17). "Press Release: Protembis Initiates Collaboration with German Accelerator Life Sciences for Planned U.S. Expansion". Aachen & Cambridge, MA. 2017-07-25
Definiens AG. (7/24/17). "Press Release: Definiens Forearms Organization for Strategic Expansion". Munich. 2017-07-24
GlaxoSmithKline plc. (7/24/17). "Press Release: GSK Submits US Regulatory Filing of Arnuity Ellipta in Children with Asthma". 2017-07-24
GlaxoSmithKline plc. (7/24/17). "Press Release: Phase II Study Results Showed Comparable Viral Suppression Rates at 96 Weeks for a Two-drug Regimen of Long-acting Cabotegravir and Rilpivirine and a Three-drug Regimen in Patients with HIV". 2017-07-24
GlaxoSmithKline plc. (7/21/17). "Press Release: GSK Announces Board and Committee Changes". 2017-07-21
Novacyt S.A.. (7/20/17). "Press Release: Novacyt Revenues Half Year 2017". Paris & Cambridge. 2017-07-20
GlaxoSmithKline plc. (7/20/17). "Press Release: ViiV Healthcare Shares Data from Its Innovative Portfolio with HIV Community at IAS 2017". London. 2017-07-20
UK Biobank. (7/20/17). "Press Release: UK Biobank Makes Available Vast Trove of Genetics Information". 2017-07-20
GlaxoSmithKline plc. (7/19/17). "Press Release: GSK Updates on UK Manufacturing Network". London. 2017-07-19
Horizon Discovery Group plc. (7/19/17). "Press Release: Acquisition and Proposed Placing to Raise £80m [Not for US, AU, CA, JP, NZ, IE, ZA or any other jursidcition where unlawful]". 2017-07-19
Novimmune S.A.. (7/18/17). "Press Release: Novimmune and Shire Sign License Agreement Deepening Bispecific Antibody Research Collaboration". Geneva. 2017-07-18
Agilent Technologies Inc.. (7/18/17). "Press Release: Hans E. Bishop to Join Agilent’s Board of Directors. CEO of Juno Therapeutics Brings Deep Knowledge of the Biopharma Industry". Santa Clara, CA. 2017-07-18
Eurofins Scientific. (7/18/17). "Press Release: Eurofins Issues EUR 650m New Euro Bond". 2017-07-18
Autolus Ltd.. (7/18/17). "Press Release: Autolus Announces Senior Leadership Appointments". London. 2017-07-18
One Nucleus. (7/17/17). "Press Release: New Chief Executive for One Nucleus". Cambridge. 2017-07-17
Eurofins Scientific. (7/17/17). "Press Release: Eurofins Announces the Potential Launch of a New Senior EUR 500m Bond on the Back of Strong M&A Activity". 2017-07-17
Silence Therapeutics plc. (7/14/17). "Press Release: Silence CEO, Ali Mortazavi, Appointed Chairman of Ultromics". 2017-07-14
G1 Therapeutics, Inc.. (7/13/17). "Press Release: G1 Therapeutics Appoints Sir Andrew Witty to Board of Directors". Research Triangle Park, NC. 2017-07-13
BASF SE. (7/13/17). "Press Release: BASF Introduces First New Class of Public Health Insecticide for Malaria Prevention in more than 30 Years". Limburgerhof. 2017-07-13
Genedata AG. (7/11/17). "Press Release: Genedata Selector Expands Partnership with AB Enzymes". Basel. 2017-07-11
BioAscent Discovery Ltd.. (7/11/17). "Press Release: BioAscent Appoints New CEO and Announces Plans to Expand Discovery Services Offering". Newhouse. 2017-07-11
Noxxon Pharma N.V.. (7/11/17). "Press Release: Noxxon Pharma Announces Prospectus Publication and Share Transfer to the Public Offering Compartment of the EuroNext Growth Market". Berlin. 2017-07-11
Freeline Therapeutics. (7/10/17). "Press Release: Freeline Therapeutics Appoints Anne Prener as Chief Executive Officer". 2017-07-10
Silence Therapeutics plc. (7/10/17). "Press Release: IP Update". 2017-07-10
Owlstone Medical Ltd.. (7/10/17). "Press Release: Owlstone Medical and Cancer Research UK (CRUK) Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease". Cambridge. 2017-07-10
Cellnovo. (7/7/17). "Press Release: Cellnovo Successfully Raises €17.5 Million from Healthcare Investors [Not for Distribution in the United States of America, Canada, Australia and Japan]". 2017-07-07
Curetis N.V.. (7/7/17). "Press Release: Curetis to Attend Key Investor and Scientific Conferences in the Third Quarter 2017". Amsterdam & Holzgerlingen. 2017-07-07
Agilent Technologies Inc.. (7/7/17). "Press Release: Agilent Technologies Acquires Raman Spectroscopy Innovator, Cobalt Light Systems". Santa Clara, CA. 2017-07-07
Cellnovo. (7/6/17). "Press Release: Cellnovo Launches a Capital Increase for Approximately €15 Million [Not for Distribution in the United States of America, Canada, Australia and Japan]". 2017-07-06
Oxford BioMedica plc. (7/6/17). "Press Release: Oxford BioMedica Announces a Major Supply Agreement". Oxford. 2017-07-06
Horizon Discovery Group plc. (7/5/17). "Press Release: Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform". Cambridge. 2017-07-05
Seventure Partners. (7/5/17). "Press Release: Push Doctor Raises $26.1M to Help People Live Longer". London. 2017-07-05
Horizon Discovery Group plc. (7/3/17). "Press Release: Horizon Discovery Announces Inclusion of Its Reference Standards in Successful FDA Approval of an Oncology Companion Diagnostic Test with Leading Next Generation Sequencing Company". Cambridge. 2017-07-03
Immunocore Ltd.. (7/3/17). "Press Release: Immunocore Announces Third Oncology Target Selected in Discovery Collaboration with GlaxoSmithKline". Oxford & Conshohocken, PA. 2017-07-03
Silence Therapeutics plc. (7/3/17). "Press Release: Change of Adviser". 2017-07-03
Silence Therapeutics plc. (7/3/17). "Press Release: Issue of Claim in the UK High Courts". 2017-07-03
Exscientia Ltd.. (7/2/17). "Press Release: Exscientia Enters Strategic Drug Discovery Collaboration with GSK. Pre-clinical Collaboration Focused on up to 10 Targets Nominated by GSK". 2017-07-02
Oxford BioMedica plc. (6/30/17). "Press Release: Oxford BioMedica Announces Refinancing of Debt Facility". London. 2017-06-30
Fortis Technologies Ltd.. (6/30/17). "Press Release: New SpeedCore C18-PFP for High Resolution LC Separations". Cheshire. 2017-06-30
Evotec AG. (6/28/17). "Press Release: Evotec Expands iPSC Drug Discovery Leadership through Strategic Collaboration with Censo Biotechnologies". Hamburg. 2017-06-28
Arix Bioscience plc. (6/28/17). "Press Release: Arix Bioscience Leads $45 Million Series B Financing Round into LogicBio Therapeutics". London. 2017-06-28
MerLion Pharmaceuticals Pte. Ltd.. (6/28/17). "Press Release: MerLion and Dstl Awarded DTRA Grant to Explore the Use of Finafloxacin against Biological Threat Agents". Singapore. 2017-06-28
Arix Bioscience plc. (6/27/17). "Press Release: Arix Bioscience Participates in $20 Million Fundraise for Mitoconix Bio". London. 2017-06-27
Mitoconix Bio Ltd.. (6/27/17). "Press Release: Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies". Ness Ziona. 2017-06-27
LogicBio Therapeutics, Inc.. (6/27/17). "Press Release: LogicBio Therapeutics Announces $50 Million in Financing to Develop Novel Gene Medicines for Pediatric Patients". Cambridge, MA. 2017-06-27
Redx Pharma plc (in administration). (6/23/17). "Press Relase: Redx Announces MHRA Approval of Its Clinical Trial Application for Porcupine Inhibitor RXC004". 2017-06-23
Evotec AG. (6/22/17). "Press Release: »Lab282« Accelerates with Second Round Funding". Hamburg. 2017-06-22
Waters Corporation. (6/22/17). "Press Release: Waters Corporation Elects Flemming Ornskov to Board of Directors". Milford, MA. 2017-06-22
Redx Pharma plc (in administration). (6/22/17). "Press Relase: Update on Suspension of Trading". 2017-06-22
Linguamatics Ltd.. (6/22/17). "Press Relase: Linguamatics Announces University of Pennsylvania Health System as Latest Enterprise NLP client". Cambridge & Boston, MA. 2017-06-22
Linguamatics Ltd.. (6/22/17). "Press Relase: Linguamatics and RealHealthData Partner to Extract Real World Evidence from Patient Narratives". Cambridge & Boston, MA. 2017-06-22
Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf. 2017-06-21
OBN (UK) Ltd.. (6/20/17). "Press Release: OBN (UK) and Eurasanté (FR) Announce the Launch of BioSeed. A New European Equity Investment Event to Support Early-Stage Companies in Life Sciences". Oxford. 2017-06-20
Merck KGaA. (6/20/17). "Press Release: Merck Ventures Creates New Immuno-Oncology Company iOnctura". Darmstadt. 2017-06-20
Debiopharm International SA. (6/20/17). "Press Release: Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor". Craigavon & Lausanne. 2017-06-20
Novacyt S.A.. (6/20/17). "Press Release: Novacyt Successfully Completes €3.0M Fundraising". Paris & Cambridge. 2017-06-20
Cell Medica Ltd.. (6/20/17). "Press Release: Cell Medica Acquires WT1 Cancer Immunotherapy from Cell and Gene Therapy Catapult". London. 2017-06-20
Parexel International Corporation. (6/20/17). "Press Release: Parexel International Enters Definitive Agreement to Be Acquired by Pamplona Capital Management for $88.10 Per Share in Cash". Boston, MA & New York, NY. 2017-06-20
Medicxi Ventures. (6/15/17). "Press Release: Medicxi Launches First $300m Late-stage Life Sciences Fund Medicxi Growth 1 (MG1), Backed by Novartis and Verily". London & Geneva. 2017-06-15
LifeArc. (6/15/17). "Press Release: LifeArc Set to Transform Medical Research Landscape". 2017-06-15
Merck KGaA. (6/15/17). "Press Release: Merck Expands Distribution Agreement with Public Health England". Darmstadt. 2017-06-15
Evotec AG. (6/14/17). "Press Release: Evotec Joins NURTuRE Consortium to Mine Unique Kidney Disease Patient Biobank". Hamburg. 2017-06-14
Mundipharma International Ltd.. (6/14/17). "Press Release: New Data Show Truxima (CT-P10) to Have Comparable Efficacy and Tolerability in Advanced Follicular Lymphoma to Reference i.v. Rituximab". Cambridge. 2017-06-14
Thermo Fisher Scientific Inc.. (6/12/17). "Press Release: Fully Automated Clinical and Specialty Chemistry Analyzers Designed to Streamline Companion Veterinary Diagnostics". Athens. 2017-06-12
Alacrita LLP. (6/9/17). "Press Release: Alacrita Appoints Anna Casse as 4th Managing Partner To Strengthen Commercial Advisory Services and Build a European Launch Platform". 2017-06-09
SepSolve Analytical Ltd.. (6/7/17). "Press Release: SepSolve Analytical Grows from Consultancy to »Complete Solution Provider«". 2017-06-07
SepSolve Analytical Ltd.. (6/7/17). "Press Release: SepSolve Analytical Opens the Door to Routine GC×GC Analyses". 2017-06-07
Biocartis Group N.V.. (6/7/17). "Press Release: MRC Technology and Biocartis Initiate Development of Liquid Biopsy Test for Breast Cancer". London & Mechelen. 2017-06-07
Grünenthal GmbH. (6/7/17). "Press Release: Grünenthal Enters Agreement with AstraZeneca to Acquire Global Rights to Migraine Treatment Zomig (Zolmitriptan)". Aachen: Athenäum. 2017-06-07
F-Star Biotechnology Ltd.. (6/4/17). "Press Release: F-star Expands Its Relationship with Merck through a New Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology". Cambridge. 2017-06-04
One Nucleus. (6/2/17). "Press Release: New Event to Advance Disruptive Thinking in Healthcare Innovation". London. 2017-06-02
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page


Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Fairtec GmbH Worldwide Event Solutions 600x60px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] – The Business Web Portal 120x600px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px